Reverse transcriptase-tRNATrp interaction occurs at regions containing or stabilized by pseudouridine residues, rather than at the anticodon.
Answers are grounded in this paper and cite their sources.
Pseudouridine-dependent sites mediate RT-tRNATrp binding; leaves open whether this interaction can be therapeutically targeted in retroviral contexts.
The basis of the specific binding of tRNATrp by avian myeloblastosis virus reverse transcriptase was studied by chemical and enzymatic modification of the RNA. Binding does not depend on recognition of the tryptophan anticodon since molecules cleaved in the anticodon are stably bound by the enzyme. Modification of pseudouridine residues in the tRNA destroys binding to reverse transcriptase. These results are consistent with a model in which reverse transcriptase-tRNATrp interaction occurs not at the anticodon, but at regions in the tRNA which contain or are stabilized by pseudouridine residues.
No takes yet. Share an insight, caveat, or question.
Hu et al. (1983) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: